Medicon Hellas S.A. (ATH:MEDIC)
Greece · Delayed Price · Currency is EUR 2.740
+0.010 (0.37%)
At close: Aug 28, 2026
Medicon Hellas Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1.73 | 1.37 | 1.32 | 2.53 | 3.04 |
Depreciation & Amortization | 1.5 | 1.74 | 1.69 | 1.63 | 1.68 |
Other Amortization | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
Loss (Gain) From Sale of Assets | -0.05 | 0.01 | -0.02 | 0 | -0.03 |
Other Operating Activities | -1.1 | -0.93 | -1.22 | -1.3 | 1.46 |
Change in Accounts Receivable | 2.31 | -0.34 | -0.91 | -1.18 | -1.3 |
Change in Inventory | -0.94 | -0.28 | -1.18 | -0.39 | -0.23 |
Change in Other Net Operating Assets | 0.94 | 0.43 | 1.19 | -0.06 | 0.17 |
Operating Cash Flow | 4.41 | 2 | 0.88 | 1.25 | 4.79 |
Operating Cash Flow Growth | 120.46% | 127.76% | -29.65% | -73.94% | 55.78% |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1.5 | -1.01 | -1.59 | -0.41 | -0.55 |
Sale of Property, Plant & Equipment | 0.05 | 0.2 | 0.03 | 0.04 | 0.11 |
Investment in Securities | - | 0.07 | - | 0 | - |
Other Investing Activities | 0.13 | 0.33 | 0.58 | 0.15 | 0.13 |
Investing Cash Flow | -1.32 | -0.4 | -0.98 | -0.21 | -0.32 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | 0.29 | 0.3 | 1.17 | 0.12 | 0.08 |
Total Debt Issued | 0.29 | 0.3 | 1.17 | 0.12 | 0.08 |
Long-Term Debt Repaid | -0.65 | -1.59 | -1.55 | -1.2 | -1.29 |
Total Debt Repaid | -0.65 | -1.59 | -1.55 | -1.2 | -1.29 |
Net Debt Issued (Repaid) | -0.35 | -1.29 | -0.38 | -1.07 | -1.2 |
Common Dividends Paid | -0.57 | -0.27 | -1.11 | -0.11 | -0.11 |
Other Financing Activities | - | - | -0.15 | - | - |
Financing Cash Flow | -0.93 | -1.55 | -1.64 | -1.18 | -1.32 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 2.16 | 0.05 | -1.75 | -0.15 | 3.16 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 2.91 | 1 | -0.72 | 0.84 | 4.24 |
Free Cash Flow Growth | 192.35% | - | - | -80.15% | 80.99% |
Free Cash Flow Margin | 16.21% | 5.49% | -3.95% | 4.05% | 19.70% |
Free Cash Flow Per Share | 0.66 | 0.23 | -0.16 | 0.19 | 0.96 |
Levered Free Cash Flow | 2.54 | 1.52 | 0.02 | 1.14 | 4.64 |
Unlevered Free Cash Flow | 2.79 | 1.88 | 0.38 | 1.3 | 4.81 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.22 | 0.58 | 0.64 | 0.26 | 0.34 |
Cash Income Tax Paid | 1.05 | 0.6 | 1.19 | 1.55 | 0.6 |
Change in Working Capital | 2.31 | -0.2 | -0.9 | -1.62 | -1.37 |